Oramed Pharmaceuticals Inc
ORMP2.128USD
+0.008+0.39%
交易中 （美东）报价延迟15分钟
86.94M总市值
亏损市盈率 TTM
关于 Oramed Pharmaceuticals Inc 公司
Oramed Pharmaceuticals Inc. 是一家拥有技术平台、从事药物解决方案研发的制药公司。该公司开发了一种口服剂型，旨在耐受胃的恶劣环境并有效递送活性生物胰岛素或其他蛋白质。其蛋白质口服递送 (POD) 技术旨在保护药物完整性并增加吸收。其产品线包括 ORMD-0801（口服胰岛素）糖尿病、ORMD-0801（口服胰岛素）NASH 和 ORMD 0901（口服 GLP-1）。其口服胰岛素 (ORMD-0801) 有可能通过在治疗早期阶段口服胰岛素来创造糖尿病治疗的新范例。其口服胰岛素胶囊 (ORMD-0801) 在早期临床试验中显示出降低肝脏脂肪含量的效果。该公司还在开发一种口服胰高血糖素样肽-1 (GLP-1) 类似物胶囊 (ORMD-0901)，这是一种刺激胰腺分泌胰岛素的肠促胰岛素激素。
公司简介
公司代码ORMP
公司名称Oramed Pharmaceuticals Inc
上市日期Apr 01, 2002
CEOMr. Nadav Kidron
员工数量13
证券类型Ordinary Share
年结日Apr 01
公司地址1185 Avenue Of The Americas, 3Rd Floor
城市NEW YORK
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编10036
电话16468441164
网址https://oramed.com/
公司代码ORMP
上市日期Apr 01, 2002
CEOMr. Nadav Kidron
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Nadav Kidron
Mr. Nadav Kidron
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.06M
+2.09%
Mr. Benjamin Shapiro
Mr. Benjamin Shapiro
Independent Director
Independent Director
1.93M
-1.56%
Dr. Miriam Kidron, Ph.D.
Dr. Miriam Kidron, Ph.D.
Chief Scientific Officer, Director
Chief Scientific Officer, Director
777.83K
-0.45%
Mr. Avraham Gabay, CPA
Mr. Avraham Gabay, CPA
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
153.01K
+11.41%
Mr. Leonard Sank
Mr. Leonard Sank
Independent Director
Independent Director
30.01K
-70.44%
Mr. Yehuda Reznick
Mr. Yehuda Reznick
Independent Director
Independent Director
19.74K
-63.39%
Dr. Daniel Aghion
Dr. Daniel Aghion
Independent Director
Independent Director
18.82K
-67.09%
Mr. Joshua Hexter
Mr. Joshua Hexter
Chief Operating and Business Officer
Chief Operating and Business Officer
--
--
Dr. Arie Mayer, Ph.D.
Dr. Arie Mayer, Ph.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Nadav Kidron
Mr. Nadav Kidron
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.06M
+2.09%
Mr. Benjamin Shapiro
Mr. Benjamin Shapiro
Independent Director
Independent Director
1.93M
-1.56%
Dr. Miriam Kidron, Ph.D.
Dr. Miriam Kidron, Ph.D.
Chief Scientific Officer, Director
Chief Scientific Officer, Director
777.83K
-0.45%
Mr. Avraham Gabay, CPA
Mr. Avraham Gabay, CPA
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
153.01K
+11.41%
Mr. Leonard Sank
Mr. Leonard Sank
Independent Director
Independent Director
30.01K
-70.44%
Mr. Yehuda Reznick
Mr. Yehuda Reznick
Independent Director
Independent Director
19.74K
-63.39%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月18日 周五
更新时间: 7月18日 周五
持股股东
股东类型
持股股东
持股股东
占比
BML Capital Management LLC
7.40%
Kidron (Nadav)
5.05%
Shapiro (Benjamin)
4.74%
Murchinson Ltd.
4.29%
Boothbay Fund Management, LLC
2.07%
Other
76.46%
持股股东
持股股东
占比
BML Capital Management LLC
7.40%
Kidron (Nadav)
5.05%
Shapiro (Benjamin)
4.74%
Murchinson Ltd.
4.29%
Boothbay Fund Management, LLC
2.07%
Other
76.46%
股东类型
持股股东
占比
Individual Investor
15.20%
Investment Advisor
9.04%
Investment Advisor/Hedge Fund
8.13%
Hedge Fund
1.17%
Research Firm
0.72%
Bank and Trust
0.06%
Other
65.68%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
124
14.01M
34.29%
-878.39K
2025Q1
140
14.12M
34.57%
-1.05M
2024Q4
166
12.68M
31.46%
-741.80K
2024Q3
167
11.86M
29.21%
-291.74K
2024Q2
182
11.21M
27.68%
-1.03M
2024Q1
228
10.28M
25.41%
-3.86M
2023Q4
234
9.69M
24.13%
+273.21K
2023Q3
243
6.84M
17.06%
-2.85M
2023Q2
244
6.81M
17.03%
-4.46M
2023Q1
244
6.64M
16.80%
-2.29M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BML Capital Management LLC
3.02M
7.39%
+376.84K
+14.25%
Mar 31, 2025
Kidron (Nadav)
2.02M
4.95%
-96.03K
-4.54%
Mar 27, 2025
Shapiro (Benjamin)
1.96M
4.81%
+34.65K
+1.80%
Jun 05, 2025
Murchinson Ltd.
1.75M
4.29%
+800.00
+0.05%
Mar 31, 2025
Boothbay Fund Management, LLC
845.49K
2.07%
+300.00
+0.04%
Mar 31, 2025
Hexter Joshua
812.17K
1.99%
+126.83K
+18.51%
Feb 11, 2025
Kidron (Miriam)
781.33K
1.91%
-6.88K
-0.87%
Mar 27, 2025
Two Sigma Investments, LP
277.42K
0.68%
-74.36K
-21.14%
Mar 31, 2025
Rathbones Investment Management Limited
236.80K
0.58%
-53.00K
-18.29%
Mar 31, 2025
Li (Xiaopeng)
218.60K
0.54%
--
--
Mar 27, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.02%
Amplify BlueStar Israel Technology ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
SPDR Portfolio Developed World ex-US ETF
0%
Avantis US Small Cap Equity ETF
0%
SPDR S&P International Small Cap ETF
0%
Dimensional US Core Equity 1 ETF
0%
Avantis US Equity ETF
0%
iShares Micro-Cap ETF
占比0.02%
Amplify BlueStar Israel Technology ETF
占比0%
Invesco NASDAQ Future Gen 200 ETF
占比0%
SPDR Portfolio Developed World ex-US ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%
SPDR S&P International Small Cap ETF
占比0%
Dimensional US Core Equity 1 ETF
占比0%
Avantis US Equity ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
